CTIM-26. PHASE II STUDY OF AZELIRAGON IN COMBINATION WITH RADIATION THERAPY IN NEWLY DIAGNOSED PATIENTS WITH MGMT-UNMETHYLATED GLIOBLASTOMA Article

Huang, Jiayi, Ahluwalia, Manmeet, Boockvar, John et al. (2024). CTIM-26. PHASE II STUDY OF AZELIRAGON IN COMBINATION WITH RADIATION THERAPY IN NEWLY DIAGNOSED PATIENTS WITH MGMT-UNMETHYLATED GLIOBLASTOMA . NEURO-ONCOLOGY, 26(Supplement_8), viii91-viii91. 10.1093/neuonc/noae165.0359

cited authors

  • Huang, Jiayi; Ahluwalia, Manmeet; Boockvar, John; Batiste, James; Jaboin, Jerry; Thotala, Dinesh; Halasz, Lia; Rammohan, Nikhil; Ney, Douglas; Malani, Rachna; Chinnaiyan, Prakash; Kotecha, Rupesh R; Mehta, Minesh; Marcus, Stephen

authors

publication date

  • November 11, 2024

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 5.1 Pharmaceuticals
  • 6.1 Pharmaceuticals
  • 6.2 Cellular and gene therapies
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Health Disparities
  • Immunotherapy
  • Minority Health
  • Neurosciences
  • Orphan Drug
  • Patient Safety
  • Radiation Oncology
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • viii91

end page

  • viii91

volume

  • 26

issue

  • Supplement_8